privia health group inc - PRVA

PRVA

Close Chg Chg %
20.66 0.12 0.58%

Pre-Market

20.78

+0.12 (0.58%)

Volume: 1.38M

Last Updated:

Sep 8, 2026, 4:00 PM EDT

Company Overview: privia health group inc - PRVA

PRVA Key Data

Open

$20.48

Day Range

20.40 - 21.43

52 Week Range

19.53 - 28.82

Market Cap

$2.64B

Shares Outstanding

127.73M

Public Float

119.16M

Beta

0.88

Rev. Per Employee

N/A

P/E Ratio

95.87

EPS

$0.23

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.07M

 

PRVA Performance

1 Week
 
0.58%
 
1 Month
 
-7.44%
 
3 Months
 
-11.31%
 
1 Year
 
-8.82%
 
5 Years
 
-29.49%
 

PRVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 19
Full Ratings ➔

About privia health group inc - PRVA

Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

PRVA At a Glance

Privia Health Group, Inc.
950 North Globe Road
Arlington, Virginia 22203
Phone 1-571-366-8850 Revenue 2.12B
Industry Life/Health Insurance Net Income 22.92M
Sector Finance 2025 Sales Growth 22.256%
Fiscal Year-end 12 / 2026 Employees 1,226
View SEC Filings

PRVA Valuation

P/E Current 95.87
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 133.352
Price to Sales Ratio 1.44
Price to Book Ratio 3.975
Price to Cash Flow Ratio 18.70
Enterprise Value to EBITDA 59.797
Enterprise Value to Sales 1.243
Total Debt to Enterprise Value 0.004

PRVA Efficiency

Revenue/Employee 1,731,518.76
Income Per Employee 18,694.127
Receivables Turnover 5.295
Total Asset Turnover 1.669

PRVA Liquidity

Current Ratio 1.602
Quick Ratio 1.602
Cash Ratio 0.844

PRVA Profitability

Gross Margin 9.399
Operating Margin 1.613
Pretax Margin 2.07
Net Margin 1.08
Return on Assets 1.802
Return on Equity 3.34
Return on Total Capital 3.069
Return on Invested Capital 3.315

PRVA Capital Structure

Total Debt to Total Equity 1.293
Total Debt to Total Capital 1.276
Total Debt to Total Assets 0.682
Long-Term Debt to Equity 0.994
Long-Term Debt to Total Capital 0.982
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Privia Health Group Inc - PRVA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.36B 1.66B 1.74B 2.12B
Sales Growth
+40.41% +22.19% +4.74% +22.26%
Cost of Goods Sold (COGS) incl D&A
1.23B 1.50B 1.57B 1.92B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.57M 6.53M 7.27M 9.91M
Depreciation
1.22M 1.17M 1.10M 739.00K
Amortization of Intangibles
3.35M 5.36M 6.16M 9.17M
COGS Growth
+35.52% +22.53% +4.26% +22.75%
Gross Income
130.21M 154.97M 169.59M 199.52M
Gross Income Growth
+112.77% +19.01% +9.43% +17.65%
Gross Profit Margin
+9.60% +9.35% +9.77% +9.40%
2022 2023 2024 2025 5-year trend
SG&A Expense
149.33M 134.32M 152.60M 165.29M
Research & Development
- - - -
-
Other SG&A
149.33M 134.32M 152.60M 165.29M
SGA Growth
-46.41% -10.05% +13.61% +8.31%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
(19.12M) 20.65M 16.98M 34.23M
Non Operating Income/Expense
542.00K 8.37M 10.89M 9.70M
Non-Operating Interest Income
542.00K 8.37M 10.89M 9.70M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(18.58M) 29.02M 27.87M 43.94M
Pretax Income Growth
+91.50% +256.19% -3.97% +57.65%
Pretax Margin
-1.37% +1.75% +1.61% +2.07%
Income Tax
(6.52M) 7.99M 10.83M 14.21M
Income Tax - Current - Domestic
509.00K 528.00K 2.01M 3.34M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(7.03M) 7.46M 8.82M 10.87M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(12.06M) 21.03M 17.04M 29.73M
Minority Interest Expense
(3.48M) (2.05M) 2.66M 6.81M
Net Income
(8.59M) 23.08M 14.38M 22.92M
Net Income Growth
+95.44% +368.83% -37.67% +59.33%
Net Margin Growth
-0.63% +1.39% +0.83% +1.08%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(8.59M) 23.08M 14.38M 22.92M
Preferred Dividends
- - - -
-
Net Income Available to Common
(8.59M) 23.08M 14.38M 22.92M
EPS (Basic)
-0.0776 0.1977 0.1205 0.1876
EPS (Basic) Growth
+95.55% +354.77% -39.05% +55.68%
Basic Shares Outstanding
110.70M 116.73M 119.40M 122.18M
EPS (Diluted)
-0.0776 0.1851 0.1145 0.1778
EPS (Diluted) Growth
+95.55% +338.53% -38.14% +55.28%
Diluted Shares Outstanding
110.70M 124.69M 125.61M 128.89M
EBITDA
(14.55M) 27.18M 24.25M 44.14M
EBITDA Growth
+93.23% +286.81% -10.79% +82.03%
EBITDA Margin
-1.07% +1.64% +1.40% +2.08%

Snapshot

Average Recommendation BUY Average Target Price 31.667
Number of Ratings 19 Current Quarters Estimate 0.091
FY Report Date 09 / 2026 Current Year's Estimate 0.258
Last Quarter’s Earnings 0.07 Median PE on CY Estimate N/A
Year Ago Earnings 0.18 Next Fiscal Year Estimate 0.417
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 13 13 13 13
Mean Estimate 0.09 0.08 0.26 0.42
High Estimates 0.13 0.12 0.32 0.60
Low Estimate 0.06 0.03 0.18 0.30
Coefficient of Variance 19.75 26.94 14.40 17.39

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 17 17 17
OVERWEIGHT 1 1 1
HOLD 1 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Privia Health Group Inc - PRVA

Date Name Shares Transaction Value
Sep 4, 2026 Opella Ernest Director 6,350 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 14, 2026 David Mountcastle EVP & Chief Financial Officer 164,853 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.67 per share 4,561,482.51
Mar 11, 2026 David Mountcastle EVP & Chief Financial Officer 161,903 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.84 per share 3,697,864.52
Mar 11, 2026 Edward Christopher Fargis EVP & General Counsel 88,660 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.15 per share 2,052,479.00
Mar 11, 2026 Edward Christopher Fargis EVP & General Counsel 83,711 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.84 per share 1,911,959.24
Mar 11, 2026 Parth Mehrotra Chief Executive Officer; Director 385,794 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.15 per share 8,931,131.10
Mar 11, 2026 Parth Mehrotra Chief Executive Officer; Director 363,879 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.84 per share 8,310,996.36
Mar 11, 2026 Parth Mehrotra Chief Executive Officer; Director 362,660 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.37 per share 8,475,364.20
Mar 11, 2026 Parth Mehrotra Chief Executive Officer; Director 343,795 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.84 per share 7,852,277.80

Privia Health Group Inc in the News